Can microbiome modification become a standard treatment for antibiotic-resistant infections?

With the rise of antibiotic-resistant bacteria, the medical community is facing an urgent need for alternative treatments. Recent studies have highlighted the potential of the human microbiome—the diverse community of microorganisms living in our bodies—to play a pivotal role in maintaining health and combating disease. By leveraging microbiome modification techniques, such as fecal microbiota transplants (FMT) and probiotics, researchers are exploring new ways to outmaneuver superbugs that have adapted to withstand traditional antibiotics. Could these innovative approaches become a frontline defense against antibiotic-resistant infections, fundamentally changing the way we treat infectious diseases?